Jump to content

 

BankFodder BankFodder

Leaderboard


Popular Content

Showing content with the highest reputation on 29/10/19 in all areas

  1. 1 point
    So selling the NHS and UK public out to US pharmaceutical companies to put control of UK medicine prices in the hands of US drug companies is now called “valuing innovation”. as in - adding right wing Tory innovation to the process of valuing (increasing the price of) medicines Channel 4 dispatches https://www.independent.co.uk/news/uk/politics/nhs-us-trade-deal-trump-boris-johnson-healthcare-drug-prices-liz-truss-a9175261.html UK officials discussed NHS at ‘secret’ meetings with US drug companies as part of trade talks Envoys sidestep ban on discussing drug prices by referring to controversial subject ‘valuing innovation’
×
×
  • Create New...